SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
Woman With Pipette And Test Tubes
Drug Development
Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
March 25, 2022
 · 
10 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, March 12
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 11, 2021
 · 
7 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Business
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress
February 10, 2023
 · 
5 min read
Drug Development
Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular EdemaRZ402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye
December 15, 2022
 · 
7 min read
Business
Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress
November 9, 2022
 · 
6 min read
Biotech Bay
Rezolute to Present at the Jefferies 2022 London Healthcare Conference
November 1, 2022
 · 
3 min read
Biotech Bay
Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting
October 20, 2022
 · 
3 min read
Business
Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Results and Highlights Company Progress
September 15, 2022
 · 
7 min read
Business
XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events
August 4, 2022
 · 
10 min read
Business
Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer
June 1, 2022
 · 
4 min read
Business
Rezolute Reports Third Quarter Fiscal 2022 Financial Results and Highlights Company Progress
May 12, 2022
 · 
7 min read
Biotech Bay
Rezolute to Host Corporate Update Call on May 4, 2022Company to Host Analyst and Investor Conference Call on Wednesday, May 4 at 4:30 p.m. ET
May 4, 2022
 · 
3 min read
Load More